Optellum develops an imaging biomarker for smart lung cancer detection.
Optellum has raised $14.0M in total funding. The most recent round was Series A. The last funding was announced in September 2022.
Optellum's investors include IQ Capital, Black Opal Ventures, Luminous Ventures, Intuitive Ventures, Mercia Fund Managers.
Optellum is headquartered in Oxford, United Kingdom.
Optellum develops an imaging biomarker for smart lung cancer detection.
Optellum is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Optellum — Funding & Investors." VCBacked, September 27, 2022, https://www.vcbacked.co/company/optellum. Accessed August 14, 2026.
VCBacked. (2022). Optellum — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/optellum
{{cite web |title=Optellum — Funding & Investors |url=https://www.vcbacked.co/company/optellum |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated